MITF and neoplasm: Next, we used our conditional MITF-dependent BRAFV600E p53M214Kubi:Switch model to trace melanoma cells from the primary tumour as it regresses and thereby determine if the cells detected at the MRD site originate from the primary tumour (Fig. 4A).